Kozeletskaia K N, Blinov V M, Karginov V A, Burmistrova V V, Siniakov A N, Golubev D B
Mol Gen Mikrobiol Virusol. 1989 Jun(6):33-8.
The two variants of influenza A/Victoria/35/72 (H3N2) virus resistant simultaneously to remantadine, deitiforin, adapromine and amantadine were obtained while passaging the virus in presence of remantadine or deitiforin. Both variants differed from the parental strain in optimal pH for hemolysis, transcriptase activity and in amino acid sequence of M2 protein. Maximal hemolytic activity of the parental strain is registered at pH 5.2, for the variants cultured in the presence of remantadine or deitiforin at pH 5.5 and 5.8, respectively. In contrast to NH4OH, remantadine and deitiforin do not exert inhibition of virus-induced hemolysis. Transcriptase activity of resistant variants is about 50% higher as compared with parental strain (enzyme source--whole virus particles or RNP). The M2 protein of the remantadine variant has 2 amino acid substitutions: 31 (Ser----Asn) and 59 (Met----Leu); the deitiforin variant has 3 substitutions: 14 (Met----Leu), 30 (Ala----Val) and 59 (Met----Leu). The phenotypic resistance of the virus seems to be determined by the mutations in the hydrophobic protein region (30,31); the other substitutions (14,59) may modify conformational structure and functional activity of the viral proteins.
在金刚乙胺或地替福林存在的情况下传代甲型流感病毒A/维多利亚/35/72(H3N2)时,获得了对金刚乙胺、地替福林、阿地溴铵和金刚烷胺同时耐药的两种病毒变体。两种变体在溶血的最佳pH值、转录酶活性以及M2蛋白的氨基酸序列方面均与亲代毒株不同。亲代毒株的最大溶血活性在pH 5.2时测得,在金刚乙胺或地替福林存在下培养的变体,其最大溶血活性分别在pH 5.5和5.8时测得。与NH4OH不同,金刚乙胺和地替福林不会抑制病毒诱导的溶血。耐药变体的转录酶活性比亲代毒株高约50%(酶来源——全病毒颗粒或核糖核蛋白)。金刚乙胺耐药变体的M2蛋白有2个氨基酸替换:31位(丝氨酸→天冬酰胺)和59位(甲硫氨酸→亮氨酸);地替福林耐药变体有3个替换:14位(甲硫氨酸→亮氨酸)、30位(丙氨酸→缬氨酸)和59位(甲硫氨酸→亮氨酸)。病毒的表型耐药似乎由疏水蛋白区域(30、31)的突变决定;其他替换(14、59)可能会改变病毒蛋白的构象结构和功能活性。